Evaluation of Gastric Insufflation Measured by Ultrasound of the Antral Surface During Optiflow Preoxygenation

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04206111

Enrollment

Registered

2019-12-20

Start date

2020-06-01

Completion date

2020-10-01

Last updated

2020-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Ultrasound

Brief summary

Check in gastric ultrasound for lack of stomach insufflation during preoxygenation with high-flow nasal cannulas

Interventions

PROCEDUREPreoxygenation

preoxygenation with high flow nasal cannula at 40l/min for 5min

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Adults Volunteers

Exclusion criteria

* History of gastric surgery * Facial or oropharyngeal abnormality

Design outcomes

Primary

Measure	Time frame	Description
no gastric insufflation	From date of randomization until the date of first documented progression, whichever came first, assessed up to 6 months	Number of Participants with no gastric insufflation

Countries

Belgium

Contacts

Primary ContactBenjamin Javillier, MD

benjamin.javillier@chuliege.be003243667180

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026